Fred Hutchinson Cancer Center is an independent, nonprofit, unified adult cancer care and research center that is clinically integrated with UW Medicine, a world leader in clinical care, research and learning. The first National Cancer Institute-designated cancer center in the Pacific Northwest, Fred Hutch’s global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy, and COVID-19 vaccines has confirmed our reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Based in Seattle, Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy, and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures for the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
This position involves working with investigators pursuing the development, and clinical translation, of innovative immunotherapy-based approaches to treat multiple myeloma and other hematologic malignancies. The environment is supportive, team oriented, and exciting. The successful applicant will be involved in experiments supporting pre-clinical and clinical projects. The specific assays to be performed include the processing of patient tissue specimens obtained from clinical protocols, validation assays on preclinical and cGMP grade clinical agents (radiolabeled monoclonal antibodies), and mouse models of radioimmunotherapy. There is also the opportunity to apply advanced cellular and molecular biology techniques (e.g., single cell RNA sequencing) to evaluate patient responses after receiving treatment with chimeric antigen receptor T-cell therapy.
In addition to job duties at Fred Hutch, this position also requires access to Seattle Cancer Care Alliance, which requires COVID-19 vaccination without exceptions.
Accordingly, as a condition of employment for this Fred Hutch position, newly hired employees must provide proof of vaccination before their first day of employment.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.